Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is currently the major global health problem. Still, it continues to infect people globally and up to the end of February 2022, over 436 million confirmed cases of COVID-19, incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Khorramdelazad, Hossein, Kazemi, Mohammad Hossein, Azimi, Maryam, Aghamajidi, Azin, Mehrabadi, Ali Zarezadeh, Shahba, Faezeh, Aghamohammadi, Nazanin, Falak, Reza, Faraji, Fatemeh, Jafari, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124632/
https://www.ncbi.nlm.nih.gov/pubmed/35618037
http://dx.doi.org/10.1016/j.ejphar.2022.175051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124632/
https://www.ncbi.nlm.nih.gov/pubmed/35618037
http://dx.doi.org/10.1016/j.ejphar.2022.175051

Ejemplares similares